Form 4 for STAA STAAR SURGICAL CO
Accepted 2025-03-14 00:00:00 ET · period of report 2025-03-12 · accession 0000950170-25-039705 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-14 | 2025-03-12 | STAA | Michna Magda | Chief Clinical, Regulatory | F - Tax | $18.00 | -2,435 | 16.1K | -13% | -$43.8K |
| D | 2025-03-14 | 2025-03-12 | STAA | Michna Magda | Chief Clinical, Regulatory | M - OptEx | $0.00 | +6,177 | 18.6K | +50% | $0 |
| D | 2025-03-14 | 2025-03-12 | STAA | Michna Magda | Chief Clinical, Regulatory | M - OptEx | $0.00 | -6,177 | 12.4K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-12 | F | D | 2,435 | $18.00 | 16,119 | D | — | — | (F2) Shares withheld by the Corporation to satisfy tax withholding obligations. (F3) Includes previously granted RSUs, which are subject to future vesting. |
| 2 | Common | Common Stock | 2025-03-12 | M | A | 6,177 | $0.00 | 18,554 | D | — | — | (F1) Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (6,177 shares) on March 12, 2025, and will vest as 1/3 (6,178 shares) on March 12, 2026, and 1/3 (6,178 shares) on March 12, 2027. |
| 3 | Derivative | Restricted Stock Units | 2025-03-12 | M | D | 6,177 | $0.00 | 12,356 | D | $0.00 · — to — | 6,177 Common Stock | (F4) Each RSU represents the right to receive one share of the Corporation's common stock upon vesting. (F1) Reflects restricted stock units (RSUs) granted to the Reporting Person on March 12, 2024. These RSUs vested as to 1/3 (6,177 shares) on March 12, 2025, and will vest as 1/3 (6,178 shares) on March 12, 2026, and 1/3 (6,178 shares) on March 12, 2027. |